Study of AZD5305 When Given in Combination With New Hormonal Agents in Patients With Metastatic Prostate Cancer (PETRANHA)

Investigator: Eleni Efstathiou, MD

Study Coordinator: Gabrielle Hayes

Status: Enrolling Number: NCT05367440

Phone: 734.419.948

Protocol Number: PRO00036844


This study will evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics, and preliminary efficacy of AZD5305 when given in combination with new hormonal agents (NHAs) in patients with Metastatic Prostate Cancer.
More to Explore